Stacking them is physiologically redundant in part: tesamorelin raises endogenous GH and downstream IGF-1, while IGF-1 LR3 adds direct IGF-1R stimulation on top
There are also women with PCOS who do not have a high weight or the above metabolic dysfunction that can worsen the condition, Dr
On the other hand, the Danish Steno-2 study found that while intensive multifactorial intervention (targeting glucose, blood pressure, lipids and other risk factors) dramatically reduced cardiovascular events and mortality by approximately 50%, it showed no significant reduction in DPN (HR 1.12), suggesting that neuropathy may be more resistant to multifactorial interventions compared with other diabetic complications [62]
The hormonal changes accompanying ageing further complicate this scenario
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Same active ingredient, different FDA indications, different coverage logic
